vs
Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and TOMPKINS FINANCIAL CORP (TMP). Click either name above to swap in a different company.
iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $194.8M, roughly 1.1× TOMPKINS FINANCIAL CORP). TOMPKINS FINANCIAL CORP runs the higher net margin — 49.4% vs 2.7%, a 46.7% gap on every dollar of revenue. On growth, TOMPKINS FINANCIAL CORP posted the faster year-over-year revenue change (152.7% vs 27.1%). TOMPKINS FINANCIAL CORP produced more free cash flow last quarter ($31.9M vs $14.5M). Over the past eight quarters, TOMPKINS FINANCIAL CORP's revenue compounded faster (63.6% CAGR vs 25.8%).
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
Tompkins Financial Corporation is a small, diversified financial services company based in Ithaca, New York. It is the parent of the Tompkins Trust Company, as well as several other banks, an insurance agency, and a wealth management division.
IRTC vs TMP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $208.9M | $194.8M |
| Net Profit | $5.6M | $96.2M |
| Gross Margin | 70.9% | — |
| Operating Margin | 1.1% | 71.7% |
| Net Margin | 2.7% | 49.4% |
| Revenue YoY | 27.1% | 152.7% |
| Net Profit YoY | 518.5% | 388.9% |
| EPS (diluted) | $0.18 | $6.72 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $208.9M | $194.8M | ||
| Q3 25 | $192.9M | $87.4M | ||
| Q2 25 | $186.7M | $82.6M | ||
| Q1 25 | $158.7M | $81.7M | ||
| Q4 24 | $164.3M | $77.1M | ||
| Q3 24 | $147.5M | $76.6M | ||
| Q2 24 | $148.0M | $72.7M | ||
| Q1 24 | $131.9M | $72.8M |
| Q4 25 | $5.6M | $96.2M | ||
| Q3 25 | $-5.2M | $23.7M | ||
| Q2 25 | $-14.2M | $21.5M | ||
| Q1 25 | $-30.7M | $19.7M | ||
| Q4 24 | $-1.3M | $19.7M | ||
| Q3 24 | $-46.2M | $18.6M | ||
| Q2 24 | $-20.1M | $15.7M | ||
| Q1 24 | $-45.7M | $16.9M |
| Q4 25 | 70.9% | — | ||
| Q3 25 | 71.1% | — | ||
| Q2 25 | 71.2% | — | ||
| Q1 25 | 68.8% | — | ||
| Q4 24 | 70.0% | — | ||
| Q3 24 | 68.8% | — | ||
| Q2 24 | 69.9% | — | ||
| Q1 24 | 66.3% | — |
| Q4 25 | 1.1% | 71.7% | ||
| Q3 25 | -4.4% | 35.6% | ||
| Q2 25 | -10.0% | 34.2% | ||
| Q1 25 | -20.5% | 31.6% | ||
| Q4 24 | -2.5% | 33.4% | ||
| Q3 24 | -34.1% | 32.0% | ||
| Q2 24 | -15.5% | 28.3% | ||
| Q1 24 | -28.9% | 30.4% |
| Q4 25 | 2.7% | 49.4% | ||
| Q3 25 | -2.7% | 27.1% | ||
| Q2 25 | -7.6% | 26.0% | ||
| Q1 25 | -19.3% | 24.1% | ||
| Q4 24 | -0.8% | 25.5% | ||
| Q3 24 | -31.3% | 24.3% | ||
| Q2 24 | -13.6% | 21.6% | ||
| Q1 24 | -34.6% | 23.2% |
| Q4 25 | $0.18 | $6.72 | ||
| Q3 25 | $-0.16 | $1.65 | ||
| Q2 25 | $-0.44 | $1.50 | ||
| Q1 25 | $-0.97 | $1.37 | ||
| Q4 24 | $-0.03 | $1.39 | ||
| Q3 24 | $-1.48 | $1.30 | ||
| Q2 24 | $-0.65 | $1.10 | ||
| Q1 24 | $-1.47 | $1.18 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $583.8M | $132.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $152.7M | $938.4M |
| Total Assets | $1.0B | $8.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $583.8M | $132.8M | ||
| Q3 25 | $565.2M | $193.5M | ||
| Q2 25 | $545.5M | $212.6M | ||
| Q1 25 | $520.6M | $193.1M | ||
| Q4 24 | $535.6M | $134.4M | ||
| Q3 24 | $522.0M | $132.3M | ||
| Q2 24 | $561.5M | $70.9M | ||
| Q1 24 | $569.1M | $57.1M |
| Q4 25 | $152.7M | $938.4M | ||
| Q3 25 | $121.9M | $788.8M | ||
| Q2 25 | $103.7M | $761.8M | ||
| Q1 25 | $86.7M | $741.4M | ||
| Q4 24 | $90.9M | $713.4M | ||
| Q3 24 | $71.8M | $719.9M | ||
| Q2 24 | $99.2M | $674.6M | ||
| Q1 24 | $90.3M | $667.9M |
| Q4 25 | $1.0B | $8.7B | ||
| Q3 25 | $995.2M | $8.5B | ||
| Q2 25 | $964.0M | $8.4B | ||
| Q1 25 | $926.1M | $8.2B | ||
| Q4 24 | $931.4M | $8.1B | ||
| Q3 24 | $909.7M | $8.0B | ||
| Q2 24 | $919.2M | $7.9B | ||
| Q1 24 | $909.8M | $7.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.2M | $38.9M |
| Free Cash FlowOCF − Capex | $14.5M | $31.9M |
| FCF MarginFCF / Revenue | 6.9% | 16.4% |
| Capex IntensityCapex / Revenue | 5.6% | 3.6% |
| Cash ConversionOCF / Net Profit | 4.70× | 0.40× |
| TTM Free Cash FlowTrailing 4 quarters | $34.5M | $105.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.2M | $38.9M | ||
| Q3 25 | $34.9M | $34.9M | ||
| Q2 25 | $27.7M | $18.9M | ||
| Q1 25 | $-7.9M | $22.2M | ||
| Q4 24 | $19.2M | $95.0M | ||
| Q3 24 | $24.3M | $21.2M | ||
| Q2 24 | $11.8M | $27.3M | ||
| Q1 24 | $-52.0M | $23.2M |
| Q4 25 | $14.5M | $31.9M | ||
| Q3 25 | $20.1M | $33.9M | ||
| Q2 25 | $17.3M | $18.3M | ||
| Q1 25 | $-17.3M | $20.9M | ||
| Q4 24 | $12.4M | $88.8M | ||
| Q3 24 | $15.5M | $18.9M | ||
| Q2 24 | $3.4M | $26.3M | ||
| Q1 24 | $-61.8M | $21.9M |
| Q4 25 | 6.9% | 16.4% | ||
| Q3 25 | 10.4% | 38.8% | ||
| Q2 25 | 9.3% | 22.1% | ||
| Q1 25 | -10.9% | 25.5% | ||
| Q4 24 | 7.5% | 115.1% | ||
| Q3 24 | 10.5% | 24.7% | ||
| Q2 24 | 2.3% | 36.2% | ||
| Q1 24 | -46.8% | 30.0% |
| Q4 25 | 5.6% | 3.6% | ||
| Q3 25 | 7.7% | 1.1% | ||
| Q2 25 | 5.6% | 0.8% | ||
| Q1 25 | 5.9% | 1.7% | ||
| Q4 24 | 4.2% | 8.1% | ||
| Q3 24 | 6.0% | 2.9% | ||
| Q2 24 | 5.7% | 1.3% | ||
| Q1 24 | 7.4% | 1.9% |
| Q4 25 | 4.70× | 0.40× | ||
| Q3 25 | — | 1.47× | ||
| Q2 25 | — | 0.88× | ||
| Q1 25 | — | 1.13× | ||
| Q4 24 | — | 4.82× | ||
| Q3 24 | — | 1.14× | ||
| Q2 24 | — | 1.74× | ||
| Q1 24 | — | 1.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
TMP
Segment breakdown not available.
